Monash BDI-WMU Alliance in Clinical and Experimental Biomedicine

Lead organisation(s): 
Biomedicine Discovery Institute, Monash University, Australia.
Wenzhou Medical University, China.
Project type: 
Research
Status: 
In progress
Summary: 
We have engaged with partners in Wenzhou, China to analyze the recent rise in AMR in their hospitals. In 2019, we opened the Monash BDI-WMU Alliance in Clinical and Experimental Biomedicine on the campus of Wenzhou Medical University. Initial assessments of one species of bacteria reveals that 15 years ago, less than ten patients per annum were infected, all of which responded to off the shelf antibiotics. Last year, 990 patients had infections s, with ~1 in 3 being AMR.
Timeframe: 
The project commenced two years ago, and will run for up to five more years (depending on funding availability)
Related topics: 
For hospitals
General public
Objective 5: Integrated surveillance and response to resistance and usage
Objective 6: A strong collaborative research agenda across all sectors
Objective 7: Strengthen global collaboration and partnerships
For more information on this research or activity: 
https://www.monash.edu/discovery-institute/lithgow-lab
Are you the owner of this research? If you want to update or request removal please email amr.website@health.gov.au or use the Register update form.
Last updated: 

Is there anything wrong with this page?